Efficacy
Also known as: Drug efficacy, Therapeutic efficacy, Emax, Intrinsic efficacy, Maximal efficacy
Efficacy is the maximum response or effect a drug can produce regardless of dose, representing its intrinsic ability to activate a receptor and generate a biological response. In pharmacology, efficacy (Emax) distinguishes full agonists from partial agonists, while in clinical contexts it measures a treatment's ability to produce desired therapeutic effects under controlled conditions.
Last updated: February 1, 2026
Two Meanings of Efficacy
The term “efficacy” has distinct meanings in pharmacology and clinical medicine:
| Context | Definition | Measure |
|---|---|---|
| Pharmacological | Maximum possible effect (ceiling) | Emax |
| Clinical | How well treatment works | Trial outcomes |
This page covers both concepts, starting with the pharmacological definition.
Pharmacological Efficacy (Emax)
The Maximum Response
Efficacy represents the ceiling of drug effect - the highest response achievable regardless of dose:
Response
100%| _____ Full agonist (high efficacy)
| /
75%| / ___ Partial agonist (moderate efficacy)
| / /
50%|/_/
|/ ___ Antagonist (zero efficacy)
25%| /
|___/____________
Dose →
Key Concepts
| Drug Type | Efficacy | Effect |
|---|---|---|
| Full agonist | 100% Emax | Achieves maximum receptor activation |
| Partial agonist | Under 100% Emax | Limited maximum response, even at high doses |
| Antagonist | 0% Emax | Blocks receptor, produces no activation |
Efficacy vs Potency
| Property | Efficacy | Potency |
|---|---|---|
| Measures | Maximum effect | Dose for effect |
| Curve position | Height (vertical) | Position (horizontal) |
| Symbol | Emax | EC50 |
| Question | How high can it go? | How much is needed? |
A drug can be highly potent but have low efficacy (effective at low doses but with a limited ceiling), or less potent with high efficacy (needs more drug but reaches full effect).
Clinical Efficacy vs Effectiveness
| Aspect | Efficacy | Effectiveness |
|---|---|---|
| Setting | Clinical trial | Real world |
| Conditions | Ideal, controlled | Typical, varied |
| Participants | Selected, monitored | General population |
| Adherence | Usually high | Variable |
| Question | ”Can it work?" | "Does it work?” |
Measuring Efficacy
Primary Endpoints
Main outcome the trial is designed to measure:
- Weight loss (obesity trials)
- HbA1c reduction (diabetes trials)
- Symptom improvement
Secondary Endpoints
Additional outcomes of interest:
- Blood pressure changes
- Quality of life
- Other metabolic markers
How Efficacy Is Reported
| Metric | Example |
|---|---|
| Absolute change | -15 lbs average |
| Percent change | -12% body weight |
| Responder rate | 70% achieved 5%+ loss |
| vs placebo | 10% more than placebo |
Efficacy Data for Major Peptides
Semaglutide 2.4mg (Wegovy)
| Endpoint | Result |
|---|---|
| Weight loss | -14.9% vs -2.4% placebo |
| ≥5% weight loss | 86% vs 32% placebo |
| ≥10% weight loss | 69% vs 12% placebo |
| ≥15% weight loss | 50% vs 5% placebo |
Tirzepatide 15mg (Zepbound)
| Endpoint | Result |
|---|---|
| Weight loss | -22.5% vs -2.4% placebo |
| ≥5% weight loss | 96% vs 28% placebo |
| ≥10% weight loss | 90% vs 9% placebo |
| ≥20% weight loss | 63% vs 1% placebo |
Factors Affecting Efficacy
Drug Factors
- Mechanism of action
- Potency and selectivity
- Pharmacokinetic profile
- Dose and formulation
Patient Factors
- Disease severity
- Genetic variations
- Concurrent medications
- Comorbidities
Study Factors
- Patient selection
- Protocol adherence
- Duration of study
- Outcome definitions
Interpreting Efficacy Claims
Questions to Ask
- Compared to what? (placebo, active drug)
- In what population?
- Over what time period?
- What was the dropout rate?
- What about non-responders?
Common Pitfalls
| Misleading Claim | Reality Check |
|---|---|
| ”Clinically proven” | At what dose? For what outcome? |
| “90% effective” | Effective at what? |
| ”Superior results” | Superior to what comparator? |
| ”Significant weight loss” | Statistically or clinically? |
From Efficacy to Real-World Use
Why real-world results may differ:
- Lower adherence outside trials
- Different patient populations
- Less monitoring and support
- Variable dosing
- Drug interactions
Frequently Asked Questions
What’s the difference between efficacy and potency?
Potency measures how much drug is needed (EC50), while efficacy measures how much effect is possible (Emax). A highly potent drug works at low doses; a highly efficacious drug produces a large maximum effect. The most desirable drugs are both potent AND efficacious, but these properties are independent.
If a drug has high efficacy, will it work for me?
High efficacy means it works well in the average trial participant, but individual responses vary. Some people respond excellently, others minimally. Efficacy data tells you the drug CAN work but doesn’t guarantee individual results.
Why is placebo-subtracted efficacy important?
Placebo groups often improve too (from lifestyle changes, natural variation, or placebo effect). Subtracting placebo response shows the drug’s true contribution beyond these factors.
What’s a clinically meaningful effect?
This depends on the condition. For weight loss, 5-10% is often considered clinically meaningful (improves metabolic health). For HbA1c, 0.5-1.0% reduction is meaningful. Regulatory and clinical guidelines define thresholds for each condition.
Related Peptides
Related Terms
Disclaimer: This glossary entry is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical questions.